Tempest Therapeutics Q4 EPS $(0.62) Beats $(3.52) Estimate
Benzinga Newsdesk 7 months ago
EarningsEarnings BeatsNews
Tempest Therapeutics (NASDAQ:TPST) reported quarterly losses of $(0.62) per share which beat the analyst consensus estimate of $(3.52) by 82.39 percent. This is a 87.77 percent increase over losses of $(5.07) per share
Tempest Therapeutics (NASDAQ:TPST) reported quarterly losses of $(0.62) per share which beat the analyst consensus estimate of $(3.52) by 82.39 percent. This is a 87.77 percent increase over losses of $(5.07) per share from the same period last year.